Innovotech Inc. (TSXV:IOT)
Canada · Delayed Price · Currency is CAD 0.1800
+0.0050 (2.86%)
At close: Apr 10, 2026
Innovotech Market Cap
Innovotech has a market cap or net worth of CAD 9.8 million as of April 10, 2026. Its market cap has increased by 164.45% in one year.
Market Cap
9.80M
Enterprise Value
8.39M
Revenue
4.53M
Ranking
n/a
PE Ratio
96.83
Stock Price
0.18
Market Cap Chart
Since November 30, 2004, Innovotech's market cap has increased from 2.20M to 9.80M, an increase of 345.75%. That is a compound annual growth rate of 7.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 9.80M | -28.89% |
| Dec 31, 2025 | 13.78M | 54.00% |
| Dec 27, 2024 | 8.95M | 206.64% |
| Dec 27, 2023 | 2.92M | -44.44% |
| Dec 29, 2022 | 5.25M | -28.95% |
| Dec 29, 2021 | 7.39M | -0.97% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rapid Dose Therapeutics | 15.55M |
| Hemostemix | 13.85M |
| Britannia Life Sciences | 13.79M |
| PreveCeutical Medical | 11.96M |
| Pharmala Biotech Holdings | 10.89M |
| Glow Lifetech | 9.61M |
| COSCIENS Biopharma | 9.01M |
| Marvel Biosciences | 8.51M |